Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma

26 Mar 2014

Abstract excerpt

// Juan Liu 1,4 , Cen Zhang 1,4 , Meihua Lin 1 , Wei Zhu 1,2 , Yingjian Liang 1 , Xuehui Hong 1,2 ,Yuhan Zhao 1,2 , Ken H. Young 3 , Wenwei Hu 1,2 , Zhaohui Feng 1 1 Department of Radiation Oncology, 2 Department of Pediatrics, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA 3 Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston , TX , USA 4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24797434
DOI: 10.18632/oncotarget.1862

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinomaPMID 24797434Read ↗

Epigenetic silencing of glutaminase 2 in human liver and colon cancersSemantic proximity Read ↗

Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasisSemantic proximity Read ↗

GSG2 Promotes Tumor Growth Through Regulating Cell Proliferation in Hepatocellular CarcinomaSemantic proximity Read ↗

GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular CarcinomaSemantic proximity Read ↗

Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.Semantic proximity Read ↗

Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cellsSemantic proximity Read ↗

Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancerSemantic proximity Read ↗

Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.Semantic proximity Read ↗

p63 regulates glutaminase 2 expressionSemantic proximity Read ↗

Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.Semantic proximity Read ↗

Elevating PKM2 Expression Indicates a Biomarker of Poor Prognosis in Patients With Liver CancerSemantic proximity Read ↗

A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.